US Patent 9850262 Proteasome activity enhancing compounds
Patent 9850262 was granted and assigned to Proteostasis Therapeutics, Inc. on December, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9850262 Proteasome activity enhancing compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
